Recruiting A Phase I Study of Mozobil in the Treatment of Patients With WHIMS NCT00967785 Conditions Agammaglobulinemia, Agranulocytosis, Blood Protein Disorders, +21 more Locations National Institutes of Health Clinical Center — Bethesda, Maryland, United States View Trial Details
Completed Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome NCT02231879 Conditions Agammaglobulinemia, Agranulocytosis, Blood Protein Disorders, +22 more Locations National Institutes of Health Clinical Center, 9000 Rockville Pike — Bethesda, Maryland, United States View Trial Details
